Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing.
Source link
Pfizer ends development of potential pill obesity treatment
Related Posts
Brazilian leader Lula hospitalized with inner ear ailment, then released
Brazil’s President Luiz Inacio Lula da Silva was diagnosed with labyrinthitis Monday after suffering from vertigo, hospital officials said. The…
U.S. applications for jobless benefits fall last week despite elevated uncertainty over Trump tariff
The number of Americans applying for unemployment benefits fell last week despite heightened uncertainty about how President Trump’s tariffs will…
Greens fight for survival as federal polls predict worst results in recent history
Polls suggest the Green Party is at risk of being wiped off Canada’s electoral map on election night, but co-Leader…